Peptilogics


Peptilogics is dedicated to revolutionizing the discovery process for novel peptide therapeutics aimed at treating serious and life-threatening diseases. By leveraging the potential of peptide biology and advanced machine learning techniques, the company is transforming drug design and development, focusing on precision engineering to create next-generation medicines.

Peptilogics Logo

Peptilogics


Patents

Generating anti-infective design spaces for selecting drug candidates

2024-09-10 • US-12087404-B2

View Details

Methods and apparatuses for generating peptides by synthesizing a portion of a design space to identify peptides having non-canonical amino acids

2024-06-11 • US-12006541-B2

View Details

Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates

2024-04-23 • US-11967400-B2

View Details

Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates

2023-12-19 • US-11848076-B2

View Details

Methods and apparatuses for a unified artificial intelligence platform to synthesize diverse sets of peptides and peptidomimetics

2023-02-21 • US-11587643-B2

View Details

Methods and apparatuses for generating peptides by synthesizing a portion of a design space to identify peptides having non-canonical amino acids

2022-11-29 • US-11512345-B1

View Details

What We Do

An investigational antibiotic peptide candidate for the treatment of periprosthetic joint infection (PJI), demonstrating potent in vitro and nonclinical activity with an acceptable safety profile in Phase I studies.



Key People

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.